DrugPatentWatch Database Preview
Details for Patent: 8,048,917
Which drugs does patent 8,048,917 protect, and when does it expire?
Patent 8,048,917 protects HORIZANT and is included in one NDA.
This patent has seventy-three patent family members in twenty countries.
Summary for Patent: 8,048,917
| Title: | Prodrugs of GABA analogs, compositions and uses thereof |
| Abstract: | The present invention provides prodrugs of GABA analogs, pharmaceutical compositions of prodrugs of GABA analogs and methods for making prodrugs of GABA analogs. The present invention also provides methods for using prodrugs of GABA analogs and methods for using pharmaceutical compositions of prodrugs of GABA analogs for treating or preventing common diseases and/or disorders. |
| Inventor(s): | Gallop; Mark A. (Los Altos, CA), Cundy; Kenneth C. (Redwood City, CA), Zhou; Cindy X. (Palo Alto, CA), Yao; Fenmei (Mountain View, CA), Xiang; Jia-Ning (Palo Alto, CA) |
| Assignee: | XenoPort, Inc. (Santa Clara, CA) |
| Application Number: | 11/110,909 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; Dosage form; Use; |
Drugs Protected by US Patent 8,048,917
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Arbor Pharms Llc | HORIZANT | gabapentin enacarbil | TABLET, EXTENDED RELEASE;ORAL | 022399-002 | Dec 13, 2011 | RX | Yes | No | Start Trial | Start Trial | Y | Y | MANAGEMENT OF POSTHERPETIC NEURALGIA (PHN) IN ADULTS | Start Trial | ||
| Arbor Pharms Llc | HORIZANT | gabapentin enacarbil | TABLET, EXTENDED RELEASE;ORAL | 022399-001 | Apr 6, 2011 | RX | Yes | Yes | Start Trial | Start Trial | Y | Y | MANAGEMENT OF POSTHERPETIC NEURALGIA (PHN) IN ADULTS | Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,048,917
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 380029 | Start Trial | |||
| Austria | 540678 | Start Trial | |||
| Australia | 2002310409 | Start Trial | |||
| Australia | 2002345664 | Start Trial | |||
| Australia | 2003247522 | Start Trial | |||
| Australia | 2003297676 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
